Workflow
NanoViricides(NNVC)
icon
Search documents
NanoViricides advances antiviral candidate NV-387 into Phase 2 trials for Mpox
Proactiveinvestors NA· 2025-07-02 12:36
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
NanoViricides touts antiviral NV-387 as tool against new COVID variant
Proactiveinvestors NA· 2025-06-18 12:36
Group 1 - Proactive is a leading provider of timely, multimedia news and investor relations management, focusing on delivering actionable business and finance news to a global audience [1][2] - The company has a strong presence in key financial hubs, including London, New York, Toronto, Vancouver, Sydney, and Perth, and specializes in medium and small-cap markets while also covering blue-chip companies and broader investment stories [2][3] - Proactive's news coverage includes various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - The company is committed to adopting advanced technologies to enhance its content creation and workflow processes, leveraging decades of expertise from its team [4] - Proactive utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans to maintain quality and best practices [5]
NanoViricides commissions animal study of broad-spectrum antiviral for measles
Proactiveinvestors NA· 2025-06-04 13:03
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
NanoViricides president backs FDA's targeted COVID booster policy shift
Proactiveinvestors NA· 2025-05-22 13:24
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]
NanoViricides advances NV-387 antiviral program, eyes Phase II trials for Mpox
Proactiveinvestors NA· 2025-05-16 13:10
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across key finance and investing hubs, including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content delivered by the team includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]
NanoViricides(NNVC) - 2025 Q3 - Quarterly Report
2025-05-15 20:31
QUARTERLY REPORT UNDER SECTION 1320 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2025 Commission File Number: 001-36081 NANOVIRICIDES, INC. (Exact name of Company as specified in its charter) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Address of principal executive offices and zip code) (203) 937-6137 (Company's telephone number, including area code) Indicate by check mark whether the Company (1) has filed ...
NanoViricides progresses antiviral portfolio as measles and MPox threats rise
Proactiveinvestors NA· 2025-05-14 13:09
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights into sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]
NanoViricides wins ethics approval for Phase II Mpox drug trial in DRC
Proactiveinvestors NA· 2025-05-08 12:58
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC
Newsfile· 2025-05-05 10:30
NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYCMay 05, 2025 6:30 AM EDT | Source: D.Boral CapitalShelton, Connecticut--(Newsfile Corp. - May 5, 2025) - NanoViricides, Inc. (NYSE American: NNVC), (the "Company"), a leading clinical stage global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, today announced its participation in the D. Boral Capital Ina ...
NanoViricides advances measles drug development amid rising US cases
Proactiveinvestors NA· 2025-04-29 13:23
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...